By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the cancer and reduced the risk of disease progression or death,

Our body receives and processes a vast number of signals. Chemical signals serve as guidance cues and ensure, for example, that immune cells arrive exactly where they are needed. Many vital processes such as sensory perception,

We’ve long known obesity leaves people at a heightened risk of disease and premature death. Now, researchers say it could also impact how early breast cancer spreads in women. Unique changes in the bodies of women with obesity are helping breast cancer to become invasive and typically more advanced,

An innovative blood test could detect hidden signs of cancer spreading earlier than CT scans and help adjust treatments in a timely manner.

Melanoma may not become steadily more dangerous with age as scientists once assumed. In a surprising discovery, researchers found that cancer spread was lowest in young mice, surged in middle-aged mice,

Obesity may change how early-stage breast cancer becomes invasive, according to a study by University of Oklahoma researchers published in The American Journal of Pathology.

Cancer kills more than 500,000 Americans each year. But today, thanks to National Institutes of Health (NIH) funding, UC San Francisco researchers are revolutionizing what we thought we knew about how cancer spreads, opening new paths to cures. For decades ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and death in late-stage studies. Read more at straitstimes.com. Read more at straitstimes.